Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
YagamiNGO:7488 -0.51%73 EV-to-EBIT is 7.06 as of Aug. 13, 2026, which is 165% above its 10-year median of 2.66. GuruFocus rates NGO:7488 with a GF Score™ of 73/100 and a GF Value™ of 円3,136.62 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 96 Medical Distribution companies, Yagami ranks better than 71.87% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Yagami's Enterprise Value is 円16,212 Mil.
Yagami's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was 円2,296 Mil. Therefore, Yagami's EV-to-EBIT for today is 7.06.
The historical rank and industry rank for Yagami's EV-to-EBIT or its related term are showing as below:
NGO:7488'
s EV-to-EBIT Range Over the Past 10 Years
Min: -1.92 Med: 2.66 Max: 12.18
Current: 7.06
During the past 13 years, the highest EV-to-EBIT of Yagami was 12.18. The lowest was -1.92. And the median was 2.66.
NGO:7488's EV-to-EBIT is ranked better than 71.87% of 96
companies
in the Medical Distribution industry
Industry Median: 11.985
vs NGO:7488: 7.06
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Yagami's Enterprise Value for the quarter that ended in Apr. 2026 was 円19,594 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yagami's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was 円2,296 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yagami EV-to-EBIT Related Terms
Yagami EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Yagami's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Yagami's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yagami EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yagami's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Yagami's EV-to-EBIT falls into.
Yagami's current Enterprise Value is 円16,212 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yagami's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was 円2,296 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yagami (NGO:7488) has a EV-to-EBIT of 7.06 as of Aug. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Yagami and its competitors. This is 165% above median its historical median of 2.66. According to the industry distribution chart, Yagami ranks #27 out of 96 companies in the Medical Distribution industry, placing it in the top 28.1%.
Is Yagami's EV-to-EBIT too high?
Yagami's current EV-to-EBIT of 7.06 is 165% above median its 10-year median of 2.66. The Medical Distribution industry median EV-to-EBIT is 11.99. Yagami's value of 7.06 is 41.1% below this industry median. Based on the distribution chart, Yagami ranks #27 out of 96 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Yagami has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yagami's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yagami ranks #27 out of 96 companies for EV-to-EBIT. This puts Yagami in the upper half of its industry. The industry median EV-to-EBIT is 11.99. Yagami's value of 7.06 is 41.1% below this benchmark. While the company's 10-year median is 2.66 vs. the industry median of 11.99, Yagami has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.99, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yagami's current EV-to-EBIT of 7.06 is 41.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Yagami and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yagami's current EV-to-EBIT is 7.06, which is 165% above median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yagami stock overvalued right now?
Based on GuruFocus' analysis, Yagami (NGO:7488) is currently considered Significantly Overvalued. The stock's GF Value™ is 円3,136.62, compared to a current price of 円4,855.00 — trading 54.8% above its estimated fair value. The current EV-to-EBIT is 7.06, which is 165% above median its 10-year median of 2.66 and 41.1% below the Medical Distribution industry median of 11.99. Yagami's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Yagami (NGO:7488), the current EV-to-EBIT is 7.06 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yagami (NGO:7488) Overvalued in 2026?
Based on GuruFocus' analysis, Yagami stock appears to be overvalued.
The current stock price of 円4,855.00 is trading 54.8% above its estimated GF Value™ of 円3,136.62.
GuruFocus considers Yagami to be Significantly Overvalued.
Key valuation signals for NGO:7488:
EV-to-EBIT: 7.06 (165% above median its 10-year median of 2.66)
GF Value™: 円3,136.62 vs. price of 円4,855.00 (54.8% above fair value)
Industry Position: 41.1% below the Medical Distribution median (#27 of 96)
No single metric tells the full story. See the NGO:7488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yagami Inc is a Japan based company engaged in providing science education equipment, laboratory tables, kitchen tables, sterilizers, nurse's office equipment, AEDs (automated external defibrillators), human body models for resuscitation education, electric heaters for keeping warm and heating, and environmental testing equipment.
73GF Score
Get the complete analysis for NGO:7488
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGO:7488 has been successfully added to your 
